Company Profile
iRhythm Stock Price, News & Analysis
- Ticker:
- IRTC
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
128.12 USD (+2.91%)
Close
Last updated: August 6, 2026
3.47B USD
Market cap
Why the stock is moving
The latest monitored company update is “iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care.” The corresponding closing-price reaction is not yet available.
Company overview
Ambulatory Cardiac Monitoring
iRhythm is a digital healthcare company focused on detecting and characterizing cardiac arrhythmias. It combines wearable biosensors, cloud-based analytics and proprietary algorithms to convert extended electrocardiographic recordings into clinically actionable reports.
Zio Platform
The Zio portfolio includes wearable ambulatory ECG services for continuous and near-real-time monitoring. The company’s products serve multiple prescribing channels and are designed to improve diagnostic yield compared with shorter-duration conventional monitoring.
Data and AI Capabilities
iRhythm has accumulated data from millions of heartbeats and uses that dataset to refine arrhythmia detection and risk prediction. Its longer-term strategy is to move from episodic diagnosis toward earlier detection and more integrated cardiac-care management.
Future catalysts
iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint. The next step matters because recurring physician and payer adoption is what turns the device into a durable franchise.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of iRhythm (IRTC)?
iRhythm (IRTC) most recently closed at 128.12 USD, a +2.91% move versus the previous session.
What is the market cap of iRhythm (IRTC)?
iRhythm currently has a market capitalization of 3.47B USD on BioPharmSignal.
What does iRhythm do?
Ambulatory Cardiac Monitoring iRhythm is a digital healthcare company focused on detecting and characterizing cardiac arrhythmias. It combines wearable biosensors, cloud-based analytics and proprietary algorithms to convert extended electrocardiographic recordings into clinically actionable reports. Zio Platform The Zio portfolio includes wearable...
On which exchange is IRTC stock listed?
iRhythm (IRTC) is associated with NASDAQ, United States, MedTech.
What is Ambulatory?
iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint.
Which conditions is iRhythm targeting with Ambulatory?
iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint.
How does iRhythm describe recent progress with Ambulatory?
iRhythm's catalysts are Zio monitor adoption, payer coverage, and the pace at which the company can expand its ambulatory cardiac-monitoring footprint.
What is Cardiac?
Ambulatory Cardiac Monitoring iRhythm is a digital healthcare company focused on detecting and characterizing cardiac arrhythmias.